Openbookopenbook
Openbook
MEDX
+3.52 · +11.66%
$33.73 · NASDAQ

Horizon Kinetics Medical ETF (MEDX) ETF Analysis | Health

Horizon Kinetics · USA
AUM:$20.2M
#– of – in Health ETFs

Educational tool only – Figures are based on historical data, holdings and expense metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Market Performance

Up 25.6% over the past year, reflecting strong price momentum.

Cost Efficiency

Ongoing charge of 0.85% — above average for this category.

What is MEDX?

The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries.

Performance Highlights

Returns (%)
Top Sectors (%)

Investment Breakdown

Strong Recent Performance
MEDX delivered 25.6% over the past year. Historical returns only — past performance is not indicative of future results.
Higher Cost Profile
Expense ratio of 0.85% is above average. Verify whether the strategy justifies the cost.
Concentrated Holdings
Top 10 holdings account for 65.9% of the ETF — significant weight in a small number of names.
ETF Information
AUM$20.2M
Expense Ratio0.85%
Dividend Yield1.22%
Holdings30
Inception DateSept 1999
Domicile–
Distribution–
Index–
ProviderHorizon Kinetics
Beta0.72
CategoryHealth
CurrencyUSD
Portfolio Impact

How would MEDX affect your portfolio?

Sign in to see exactly what adding this ETF changes — sector exposure, yield, diversification, volatility. Real numbers from your actual holdings.

Sign in
Example preview
6168
+7 points · better diversified

Chart Tools

My Portfolio

Sign in to overlay your portfolio on the chart.

Sign in
Compare Equity
Uses ISF.L (iShares FTSE 100 ETF)
Indicators

Performance Metrics

Historical returns

6M
+3.2%
1Y
+29.6%
3Y
+30.4%
5Y
+27.8%
OpenBook InsightIf you had invested £10,000 in MEDX 5 years ago, it would have grown to £12,779 — a gain of £2,779.

Annual Returns

Calendar year performance

MEDX delivered positive returns in 2 of the last 4 calendar years.
YearMEDX
2026 YTD+10.1%
2025+27.8%
2024-6.7%
2023-5.3%
CAGR 3yr+4.1%
2/4 positive yearsAvg return: +6.5%Worst year: -6.7% (2024)

Technical Analysis Summary

Automated insights from historical price action and indicators

Technical Regime: POSITIVE
Trend Strength
100%
Positive
Volatility
19.5%
Low
Momentum
+5.2%
30-day change
Support Level
34.63
Key floor
Key Insights
  • Price is currently trading above all key moving averages.
  • Monitor key support and resistance levels as part of broader risk assessment.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.